Page last updated: 2024-08-24

irganox 1010 and bisphenol a

irganox 1010 has been researched along with bisphenol a in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bercu, J; Binazon, O; Broschard, T; Bruen, U; Callis, CM; Cruz, MT; Dolan, DG; Erexson, GL; Giddings, A; Glowienke, S; Li, K; Martin, EA; Masuda-Herrera, M; Nagao, LM; Parris, P; Stanard, B; Stults, CLM; Whelan, G1

Other Studies

1 other study(ies) available for irganox 1010 and bisphenol a

ArticleYear
Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies.
    Regulatory toxicology and pharmacology : RTP, 2020, Volume: 118

    Topics: Animals; Benzhydryl Compounds; Butylated Hydroxytoluene; Cricetinae; Decision Trees; Drug Contamination; Drug Packaging; Humans; Mice; Patient Safety; Pharmaceutical Preparations; Phenols; Phosphites; Rats; Risk Assessment; Toxicity Tests; Toxicokinetics

2020